PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. From important changes to engaging physicians to finding out how new technologies will help address HCPs education needs, hear what our specialist had to say.

Education 59

Education Physicians Healthcare Healthcare 59

pharmaphorum

JANUARY 11, 2023

Roche tops biopharma partnering podium. One in five partnerships were with healthcare systems and providers, which are being “driven by a need for greater productivity and are demanding end to-end solutions that don’t require a patchwork of software solutions or apps for a single patient or physician,” says the report.

Biopharma 75

Biopharma Specialization Physicians Healthcare 75

PM360

MAY 21, 2024

sarah.caldwell@veeva.com SARAH CALDWELL General Manager Veeva Crossix Analytic Consumers’ TV viewing habits are changing, and streaming video continues to catapult in popularity, unearthing new opportunities for biopharma advertisers to reach patients in more targeted ways. According to Nielsen, streaming accounts for 38% of viewership hours.

Media 105

Media Healthcare Healthcare Marketing 105

MedCity News

OCTOBER 24, 2024

Two chief information security officers offer some advice at a cybersecurity panel at HLTH. The post How To Spot Deepfakes and Other Cybersecurity Panel Takeaways from HLTH appeared first on MedCity News.

Physicians 321

Physicians Biopharma Healthcare Healthcare 321

PM360

SEPTEMBER 21, 2023

This “synchronization” helps biopharmas such as Pfizer maximize marketing and field efforts across their organizations to improve engagement with healthcare professionals (HCPs). However, many biopharmas fail to synchronize engagement and digital touchpoints in a timely manner for 73% of HCPs.

Marketing 105

Marketing Media CRM Sales 105

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. Which physicians see these patients? sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

Pharma Marketing Network

MARCH 25, 2022

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. But one key member is often omitted: the patient’s caregiver.

Pharma 98

Pharma Education Training Transportation 98

Clarivate

JULY 5, 2023

This pricing strategy is likely to become more common to satisfy the needs of the payers and the pharmacy benefit managers,” said Hamzah Aideed, Senior Manager of Healthcare Research and Data Analytics, Biosimilars at Clarivate, in a recent webinar discussing the impact of HUMIRA ® biosimilars on the US market.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Pharmaceutical Technology

APRIL 25, 2023

Global healthcare company AmerisourceBergen has launched a cell and gene therapy (CGT) integration hub. The new system can be integrated with biopharma or provider-facing platforms to enable the exchange of information in real time.

Customer Relationship Management 52

Customer Relationship Management Healthcare Provider Relationship management Distribution 52

pharmaphorum

SEPTEMBER 12, 2022

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. Knowledge can change the course of healthcare for all and alter the course of care for individuals in need. Tailored oncology.

Patients 105

Patients Medicine FDA Healthcare 105

Medgadget

FEBRUARY 17, 2023

Currently, the awkwardness of conventional laparoscopic tools keeps many physicians from using them in a variety of cases. ” An attractive proposition in a world in which technology has contributed significantly to the distancing of physicians from their patients, usually leading to negative side effects.

Physicians 80

Physicians Engineering Leads Side effects 80

Pharmaceutical Representative Training

JANUARY 29, 2025

Biosimilars: The Future of Affordable Biologic Therapies Biologics are some of the most expensive forms of therapy in modern healthcare. The existence of biosimilars is meant to address both the cost and access of biologics in the healthcare industry. [1]

Marketing 52

Marketing Healthcare Healthcare Physicians 52

PM360

NOVEMBER 27, 2023

I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content. Pooja Ojala: How do you approach marketing to adapt to today’s healthcare landscape?

Marketing 105

Marketing Customer Relationship Management Relationship management CRM 105

Clarivate

OCTOBER 25, 2023

Unlike in Part D, Part B drugs are physician administered and there is less certainty regarding which drugs will be tapped for negotiations (i.e., How the IRA could affect treatment choice While price negotiations are intended to lower Medicare costs, they also present a challenge to physician practice economics.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Veeva

AUGUST 15, 2021

Veeva OpenData has one of the most accurate customer reference data sets available in the market and provides access to a wide profile of healthcare professionals and healthcare organisations in Singapore. This enables field reps to target the right physicians and opportunities in real time.

Sales 52

Sales Healthcare Healthcare Healthcare Provider 52

Legacy MEDSearch

MAY 19, 2023

Through this collaboration, healthcare providers are able to access clinically relevant heart rhythm analyses and actionable reports via PaceMateLIVE to monitor at-risk patients; identify underlying arrhythmias, including atrial fibrillation (AF); and drive improvements to patient care and clinical outcomes.

Healthcare Provider 52

Healthcare Provider Management Healthcare Healthcare 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Communication and follow-up with the physician. Adherence management. Benefits investigation. Patient monitoring for safety and efficacy.

Specialization 45

Specialization Leads Pharma Side effects 45

Clarivate

MARCH 12, 2024

For the approximately 10% of biopharma candidates that actually manage to make it to clinical trials, many fail to achieve enough revenue once they reach the market to justify the R&D effort. In fact, one-third of drugs launched over a recent 10-year period fell short of sales expectations.

Government 52

Government Marketing Physicians Biopharma 52

Clarivate

MAY 24, 2023

In recent years, FDA has increasingly shown an openness to surrogate endpoints as the basis for approval of a therapy,” said Bethany Kiernan, Director of Healthcare Research Analytics for Infectious, Niche and Rare Diseases at Clarivate.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst. Pillo, Senior Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

Medgadget

MARCH 2, 2023

To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources.

Manufacturing 82

Manufacturing Leads Patients Medicine 82

Eversana Intouch

FEBRUARY 23, 2023

Biopharma valuations are down, especially for public and earlier-stage companies. Healthcare delivery was unable to recover after the peak of the pandemic, and is still limping. Shifts in government healthcare policy and funding. Implications of economic volatility abound: Patients: Market access gaps. Formulary changes.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Biopharma valuations are down, especially for public and earlier-stage companies. Healthcare delivery was unable to recover after the peak of the pandemic, and is still limping. Shifts in government healthcare policy and funding. Implications of economic volatility abound: Patients: Market access gaps. Formulary changes.

Marketing 52

Marketing Pharma Patients Insurance 52

PM360

AUGUST 7, 2024

Whether you’re a social media manager aiming to enhance engagement, a medical affairs professional measuring the impact of healthcare initiatives, or a marketer refining campaign effectiveness, it is important to understand how to create the best possible outcome for your campaigns and programs.

Media 52

Media Education Physicians Marketing 52

Clarivate

MAY 24, 2022

The consortium aims to promote awareness for rare diseases within the healthcare community and general public, address the impending issue of drug availability and improve the quality of life of rare disease patients. Gain access to intelligence on Mainland China’s healthcare market and disease-specific trends. References. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

PM360

JUNE 16, 2023

This may be scary to some in biopharma, but partnering closely with patients increases the likelihood for success. If an advocacy group has yet to be formed to support a specific disease, well-established and connected organizations such as NORD have a broader reach and influence within the healthcare community.

Patients 98

Patients Pharma Education Recruitment 98

Clarivate

JUNE 22, 2023

Questions such as where the patients are, and who and where the prescribing physicians are, can now be answered with pinpoint accuracy. The inclusion of advanced analytics enables RWD to go further than ever before, creating a complementary and robust data set that describes the market for a particular drug.

Patients 52

Patients Electronics Medical Distribution 52

Clarivate

DECEMBER 7, 2021

The pandemic has worsened the healthcare inequities facing many marginalized communities, including Black Americans. Telehealth offers one means of addressing disparities – but healthcare stakeholders must step up to make it sustainable and effective in closing the gaps. The reasons for this disparity are many and complex.

Healthcare 52

Healthcare Healthcare Transportation Physicians 52

PM360

JUNE 24, 2024

Yet, reaching and engaging such niche patient populations and the healthcare professionals (HCPs) who service them can be a challenge. How many touchpoints does the patient have with the healthcare system and which stakeholders do they interact with the most? It all starts with deeply understanding the patient journey.

Patients 118

Patients Education Healthcare Healthcare 118

Clarivate

AUGUST 17, 2022

Grace tells us about her experience as a physician and discusses healthcare literacy and education at the point of care. Better access to physicians and better funding of health systems in general are therefore among the many targets listed under SDG 3: Good health and wellbeing.

Healthcare 52

Healthcare Healthcare Patients Physicians 52

Clarivate

OCTOBER 10, 2022

The biochemically recurrent treatment setting is heterogenous with no clear consensus on timing of hormonal therapy and duration of therapy among physicians. If approved, ERLEADA is likely to compete with Pfizer’s XTANDI®, which is also poised to enter this setting and may benefit from greater physician familiarity. Key ESMO findings.

Marketing 52

Marketing Safety Patients Competition 52

Clarivate

OCTOBER 7, 2021

As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate oncology experts sifted through the more than 2,800 abstracts that were accepted for presentation at the ESMO 2021 Virtual Conference and selected their top picks. Kisqali in the battle of the CDK4/6 inhibitors 3.

Patients 91

Patients Safety Marketing Physicians 91

Clarivate

DECEMBER 1, 2021

As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate experts have selected their top picks from the AHA21 Scientific Sessions. In the following article, we present our analysis of five featured abstracts and our key takeaways for healthcare executives.

Patients 52

Patients Safety Management Marketing 52

PM360

DECEMBER 14, 2023

“We’re now leveraging our expertise in communicating with healthcare professionals to deliver essential information and practical tools to physicians and other healthcare providers to help them address the challenges faced by patients with chronic illness.”

Physicians 52

Physicians Pharma Medical Patients 52

European Pharmaceutical Review

DECEMBER 20, 2022

The upsurge in digital healthcare during the COVID-19 pandemic has catalysed changes in clinical trial recruitment and participation. Digital technologies may also facilitate patient recruitment through collaborations with healthcare services and academia”.

Medicine 105

Medicine Recruitment Consulting Patients 105

Clarivate

AUGUST 20, 2024

In 2026, CMS will select up to 15 additional Part B or Part D drugs for negotiations that take effect in 2028, and up to 20 additional drugs every year thereafter (Part B covers physician-administered drugs, including infusions of complex biologics).

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

Clarivate

DECEMBER 14, 2023

Pharmaceutical benefit managers, M&A activity among integrated delivery networks, disruption by nontraditional healthcare entities, enrollment, and the 2024 presidential election are five areas to pay attention to moving into 2024. Clarivate experts explain why these topics are ones to watch in 2024.

Marketing 52

Marketing Healthcare Healthcare Insurance 52